Correlation Between Tikun Olam and Nextage Therapeutics

Can any of the company-specific risk be diversified away by investing in both Tikun Olam and Nextage Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tikun Olam and Nextage Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tikun Olam Cannbit and Nextage Therapeutics, you can compare the effects of market volatilities on Tikun Olam and Nextage Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tikun Olam with a short position of Nextage Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tikun Olam and Nextage Therapeutics.

Diversification Opportunities for Tikun Olam and Nextage Therapeutics

0.24

Correlation Coefficient

Tikun Olam  Nextage Therapeutics

Modest diversification

The 3 months correlation between Tikun and Nextage is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Tikun Olam Cannbit and Nextage Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nextage Therapeutics and Tikun Olam is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tikun Olam Cannbit are associated (or correlated) with Nextage Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nextage Therapeutics has no effect on the direction of Tikun Olam i.e., Tikun Olam and Nextage Therapeutics go up and down completely randomly.

Pair Corralation between Tikun Olam and Nextage Therapeutics

Assuming the 90 days trading horizon Tikun Olam Cannbit is expected to under-perform the Nextage Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Tikun Olam Cannbit is 1.28 times less risky than Nextage Therapeutics. The stock trades about -0.09 of its potential returns per unit of risk. The Nextage Therapeutics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  6,700  in Nextage Therapeutics on September 4, 2024 and sell it today you would earn a total of  1,010  from holding Nextage Therapeutics or generate 15.07% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Tikun Olam Cannbit  vs.  Nextage Therapeutics

Tikun Olam Cannbit

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tikun Olam Cannbit has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Nextage Therapeutics

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Nextage Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Nextage Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Tikun Olam and Nextage Therapeutics

The main advantage of trading using opposite Tikun Olam and Nextage Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tikun Olam position performs unexpectedly, Nextage Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nextage Therapeutics will offset losses from the drop in Nextage Therapeutics' long position.

The idea behind Tikun Olam Cannbit and Nextage Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.